2 Sources
[1]
Kevin Weil raising $150M for AI science startup after OpenAI
Business Insider noted that terms remain unsettled and are subject to revision, and that Weil did not respond when approached for comment. The exact nature of the startup has not been disclosed, but Weil has pitched it as a vehicle for gathering scientific data to train AI models. Weil left OpenAI earlier this year after holding the chief product officer role and subsequently taking charge of science initiatives; among these was Prism, a platform built to integrate cutting-edge AI models into the day-to-day work of researchers.
[2]
Kevin Weil Left OpenAI 4 Months Ago. Now He's Seeking $150 Million for a Startup With No Public Product
Kevin Weil is reportedly seeking $150 million for a new AI startup at a valuation of at least $750 million -- even though he has yet to publicly reveal its name or product. The 43-year-old former OpenAI chief product officer has pitched the company as a way to gather scientific data for AI models, Business Insider reported Tuesday, citing three people familiar with the discussions. The terms are not final. Exactly how Weil plans to collect that data -- whether through its own laboratories, partnerships, acquired datasets or software embedded in existing labs -- remains unclear. For Weil, the startup follows a rapid turn from building consumer technology to trying to change how science gets done. He joined OpenAI as chief product officer in June 2024 after earlier product leadership roles at Twitter and Instagram and a stint as president of product and business at satellite-data company Planet. Less than a year and a half later, he moved into OpenAI's research organization to start OpenAI for Science. He left OpenAI in April after a little less than two years at the company, saying the science initiative was being decentralized across other research teams. By then, he had overseen Prism, an AI workspace designed to bring frontier models directly into scientists' research and writing. His new venture appears to be targeting a different part of the stack: gathering the data those AI systems need to make discoveries. The lab race Weil won't be the first to chase it. Periodic Labs, founded by former OpenAI researcher Liam Fedus and former Google DeepMind researcher Ekin Dogus Cubuk, raised a $300 million seed round last year to build AI scientists and the autonomous laboratories in which they operate. Lila Sciences raised a $350 million Series A to scale what it calls "AI Science Factories," bringing its total funding to $550 million.
Share
Copy Link
Former OpenAI chief product officer Kevin Weil is raising $150 million for a new AI science startup at a $750 million valuation, just four months after departing the company. The venture aims to gather scientific data for AI models, though details about its product and data collection methods remain undisclosed.
Kevin Weil, who departed OpenAI in April 2025, is raising $150 million for a new AI startup at a valuation of at least $750 million
2
. The 43-year-old former chief product officer has pitched the company as a vehicle for gathering scientific data to train AI models1
, though the startup's name and product remain publicly undisclosed. According to Business Insider, terms are not final and remain subject to revision1
. Weil did not respond when approached for comment.
Source: Inc.
The exact mechanisms for how Weil plans to gather scientific data for AI models remain unclear. Potential approaches include operating its own laboratories, forming partnerships, acquiring datasets, or embedding software in existing labs
2
. This ambiguity raises questions about differentiation in an increasingly crowded field of AI-powered scientific research ventures.Weil's journey to launching an AI science startup follows a rapid pivot from consumer technology to scientific applications. He joined OpenAI as chief product officer in June 2024 after product leadership roles at Twitter and Instagram, plus a stint as president of product and business at satellite-data company Planet
2
. Less than two years into his OpenAI tenure, Weil transitioned from the chief product officer role to lead science initiatives within the research organization.During his time overseeing OpenAI for Science, Weil developed Prism, a platform designed to integrate cutting-edge AI models into researchers' day-to-day work
1
. The AI workspace aimed to bring frontier models directly into scientists' research and writing processes2
. He departed OpenAI after the science initiative was decentralized across other research teams, suggesting a strategic shift within the company's approach to AI models in research workflows.Weil's new venture appears focused on a different part of the AI stack than his previous work at OpenAI. Rather than building tools that apply AI models to scientific research, the startup targets data collection—the foundational layer that AI systems need to make AI-driven discoveries
2
. This positions the company as infrastructure for the broader scientific AI ecosystem, potentially serving as a data supplier to other platforms and research institutions.The focus on scientific data acquisition reflects growing recognition that quality training data represents a critical bottleneck for advancing AI capabilities in specialized domains. Scientific data presents unique challenges compared to text or image data scraped from the internet, requiring structured collection, validation, and domain expertise.
Related Stories
Weil enters a competitive landscape where well-funded players are already pursuing similar visions. Periodic Labs, founded by former OpenAI researcher Liam Fedus and former Google DeepMind researcher Ekin Dogus Cubuk, raised a $300 million seed round last year to build AI scientists and the autonomous laboratories in which they operate
2
. Lila Sciences has gone even further, raising a $350 million Series A to scale what it calls "AI Science Factories," bringing its total funding to $550 million2
.These competitors are building end-to-end solutions that combine data generation with AI-powered analysis. Weil's approach of focusing specifically on scientific data collection could prove complementary or face challenges differentiating from more comprehensive offerings. The ability to secure $150 million before revealing a product suggests investors are betting heavily on Weil's track record and vision, despite the competitive dynamics.
The timing of Weil's fundraise coincides with intensifying interest in applying AI to accelerate scientific discovery across fields from drug development to materials science. Whether his focused approach to gathering scientific data will prove more effective than integrated lab-and-AI solutions remains to be seen, but the substantial valuation indicates confidence that data infrastructure represents a valuable position in the emerging AI science ecosystem.
Summarized by
Navi
06 Jun 2025•Startups

02 Oct 2025•Science and Research

18 Feb 2025•Startups

1
Science and Research

2
Technology

3
Technology
